Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages
暂无分享,去创建一个
[1] J. Fantini,et al. Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia , 2021, Journal of Infection.
[2] D. Standley,et al. An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies , 2021, Cell.
[3] A. Iafrate,et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity , 2021, Cell.
[4] H. Jäck,et al. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies , 2021, Cell.
[5] C. Creech,et al. SARS-CoV-2 Vaccines. , 2021, JAMA.
[6] Y. Kawaoka,et al. Antibody titers against SARS-CoV-2 decline, but do not disappear for several months , 2021, EClinicalMedicine.
[7] Bjoern Peters,et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection , 2021, Science.
[8] G. Zimmer,et al. No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection , 2020, bioRxiv.
[9] S. Perlman,et al. SARS-CoV-2-induced immune activation and death of monocyte-derived human macrophages and dendritic cells. , 2020, The Journal of infectious diseases.
[10] F. Wu,et al. Antibody-dependent enhancement (ADE) of SARS-CoV-2 infection in recovered COVID-19 patients: studies based on cellular and structural biology analysis , 2020, medRxiv.
[11] F. Krammer. SARS-CoV-2 vaccines in development , 2020, Nature.
[12] S. Kent,et al. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies , 2020, Nature Microbiology.
[13] M. Nandi,et al. ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis , 2020, Cytokine.
[14] J. Ravetch,et al. The role of IgG Fc receptors in antibody-dependent enhancement , 2020, Nature Reviews Immunology.
[15] Nicolas Carlier,et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients , 2020, Science.
[16] R. Spreafico,et al. A perspective on potential antibody-dependent enhancement of SARS-CoV-2 , 2020, Nature.
[17] L. Montaner,et al. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts , 2020, Journal of leukocyte biology.
[18] Malik Peiris,et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures , 2020, The Lancet Respiratory Medicine.
[19] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[20] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[21] H. Katoh,et al. Development of Genetic Diagnostic Methods for Detection for Novel Coronavirus 2019(nCoV-2019) in Japan , 2020 .
[22] J. Luban. SARS-CoV-2 , 2020 .
[23] Qin Ning,et al. Clinical and immunological features of severe and moderate coronavirus disease 2019 , 2020 .
[24] Lilin Zhang,et al. The alternatively spliced porcine Fc&ggr;RI regulated PRRSV‐ADE infection and proinflammatory cytokine production , 2019, Developmental and comparative immunology.
[25] P. Charneau,et al. A Japanese Encephalitis Virus Vaccine Inducing Antibodies Strongly Enhancing In Vitro Infection Is Protective in Pigs , 2017, Viruses.
[26] J. Taubenberger,et al. IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity , 2017, Science.
[27] P. Shi,et al. A novel reporter system for neutralizing and enhancing antibody assay against dengue virus , 2014, BMC Microbiology.
[28] P. Bruhns. Properties of mouse and human IgG receptors and their contribution to disease models. , 2012, Blood.
[29] W. Ouwehand,et al. The Fc-receptor III of cultured human monocytes. Structural similarity with FcRIII of natural killer cells and role in the extracellular lysis of sensitized erythrocytes. , 1990, Journal of immunology.